Canada· CA-DIN-02495244
VASCEPA
A other lipid modifying agents product containing icosapent ethyl, registered in Canada by HLS THERAPEUTICS INC. The same ATC class is registered in 6 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Icosapent ethyl is registered in 6 of 19 countries.
Countries holding a registration under ATC C10AX (other lipid modifying agents), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 3 of them publish a price we can compare per daily dose
Icosapent ethyl · ATC C10AX
6 / 19 countries
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Switzerlandprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- ICOSAPENT ETHYL
- Manufacturer
- HLS THERAPEUTICS INC
- Country
- Canada (CA)
- ATC code
- C10AX
- ATC class
- Other lipid modifying agents
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Icosapent ethyl in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesIcosapentDr. Reddy's Laboratories, Inc.
- Japanイコサペント酸エチル持田製薬
- CzechiaVAZKEPARecordati Industria Chimica e Farmaceutica S.p.A., Milano
- FinlandVazkepaOrifarm Oy
- SwitzerlandVazkepa 998 mg, WeichkapselnRECORDATI AG
- NetherlandsVazkepa 998 mg zachte capsulesRecordati Industria Chimica e Farmaceutica S.p.A.
- NorwayVazkepaRecordati Industria Chimica e Farmaceutica S.p.A.
- SwedenVazkepa 998 mg Kapsel, mjukRecordati Industria Chimica e Farmaceutica S.p.A.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vazkepa
- Liechtenstein · Vazkepa
- Norway · Vazkepa
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/84035199-da64-4b16-95a4-bf7da5c8e87c GET /v1/drugs/84035199-da64-4b16-95a4-bf7da5c8e87c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02495244",
"form": "CAPSULE",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "C10AX",
"schedule": [
"Prescription"
],
"drug_code": "98517",
"strengths": [
"1 G"
],
"ahfs_class": null,
"substances": [
"ICOSAPENT ETHYL"
],
"product_categorization": null
}See everything about icosapent ethyl.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.